Status:
ACTIVE_NOT_RECRUITING
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Multiple Sclerosis
Cognitive Dysfunction
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with multiple sclerosis (MS). ...
Eligibility Criteria
Inclusion
- Age 20 - 65 years
- Literate, English-speaking with grade 12 or equivalent in education
- Self-reported diagnosis of MS
- Self-reported cognitive/memory difficulties
- Telephone and internet access
Exclusion
- Cognitive dysfunction that precludes participation in giving informed consent
- Significant visual impairment precluding reading or writing
- No reliable telephone or internet access
- Acute psychiatric illness
- History of progressive neurodegenerative disease (dementia)
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2028
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06145737
Start Date
January 2 2024
End Date
January 1 2028
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock
Lebanon, New Hampshire, United States, 03756